Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
15.64
+0.01 (0.06%)
At close: Feb 13, 2026

SHA:603739 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,3521,2821,1771,1351,110936.23
Other Revenue
38.9738.9721.4828.4240.4824.02
1,3911,3211,1991,1631,151960.25
Revenue Growth (YoY)
9.97%10.16%3.07%1.07%19.85%13.40%
Cost of Revenue
764.87728.42648.46662.86620.4495.66
Gross Profit
626.07592.34550.44500.3530.43464.59
Selling, General & Admin
355.68343.98314.46297.58285257.92
Research & Development
137.16118.22110.68102.4100.9479.91
Other Operating Expenses
8.9111.799.198.788.968.67
Operating Expenses
510.37477.91447.32420.62400.69352.79
Operating Income
115.7114.44103.1279.68129.74111.79
Interest Expense
-20.97-21.88-15.22-7.17-2.12-1.78
Interest & Investment Income
-1.5383.937.916.09
Currency Exchange Gain (Loss)
0.470.470.583.21-1.18-2.3
Other Non Operating Income (Expenses)
-3.41-2.97-1.62-8.46-1.88-0.45
EBT Excluding Unusual Items
91.7891.5894.8771.18132.46113.35
Gain (Loss) on Sale of Investments
33.827.089.220.210.430.45
Gain (Loss) on Sale of Assets
-0.040.13-0.250.29-0.050.14
Asset Writedown
0.27-0.07-2.75---0.68
Other Unusual Items
23.5624.7321.4130.5138.5626.88
Pretax Income
149.39123.44122.5102.19171.4140.15
Income Tax Expense
35.3631.2719.6416.7821.3117.84
Earnings From Continuing Operations
114.0392.17102.8685.41150.1122.3
Minority Interest in Earnings
-30.46-29.53-22.15-15.57-17.52-13.33
Net Income
83.5762.6480.7169.84132.57108.98
Net Income to Common
83.5762.6480.7169.84132.57108.98
Net Income Growth
26.18%-22.39%15.56%-47.32%21.65%40.16%
Shares Outstanding (Basic)
252251252249246227
Shares Outstanding (Diluted)
252251252259246227
Shares Change (YoY)
-1.15%-0.66%-2.50%5.36%8.14%6.37%
EPS (Basic)
0.330.250.320.280.540.48
EPS (Diluted)
0.330.250.320.270.540.48
EPS Growth
27.65%-21.88%18.52%-50.00%12.50%31.76%
Free Cash Flow
80.5190.69-62.05-246.72-404.06-38.83
Free Cash Flow Per Share
0.320.36-0.25-0.95-1.65-0.17
Dividend Per Share
0.1000.1000.1000.1000.1600.143
Dividend Growth
----37.50%11.97%-
Gross Margin
45.01%44.85%45.91%43.01%46.09%48.38%
Operating Margin
8.32%8.66%8.60%6.85%11.27%11.64%
Profit Margin
6.01%4.74%6.73%6.00%11.52%11.35%
Free Cash Flow Margin
5.79%6.87%-5.18%-21.21%-35.11%-4.04%
EBITDA
253.58224.85176.92145.39181.44154.66
EBITDA Margin
18.23%17.02%14.76%12.50%15.77%16.11%
D&A For EBITDA
137.88110.4173.7965.7151.742.87
EBIT
115.7114.44103.1279.68129.74111.79
EBIT Margin
8.32%8.66%8.60%6.85%11.27%11.64%
Effective Tax Rate
23.67%25.33%16.03%16.42%12.43%12.73%
Revenue as Reported
1,3911,3211,1991,1631,151960.25
Advertising Expenses
-7.096.595.025.675.43
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.